01 1Viatris
01 1PLERIXAFOR USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-11-13
Pay. Date : 2018-09-25
DMF Number : 32341
Submission : 2018-01-07
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PLERIXAFOR USP, with a corresponding US DMF Number 32341.
Remarkably, this DMF maintains an Active status since its submission on January 07, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 13, 2018, and payment made on September 25, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
